Tatton Consulting supported Birmingham-based pharmaceutical formulation company Mesox in its successful application to Innovate UK Smart grants: January 2023, awarded £357,249 by Innovate UK for the project ASD3MAP: Amorphous Solid Dispersion Digital Design and Manufacturing Platform for rapid and resource-efficient development of bioavailable medicines.
About the funded R&D project
Many promising drug molecules fail on bioavailability, and amorphous solid dispersions are a route around that. Developing them is slow and material-intensive. MESOX, with Aston University, spends 18 months refining molecular dynamics models and integrating commercial material science and simulation tools into an in-silico formulation development platform, shifting the work from bench trials to computation.
Award details
- Total project grant: £357,249
- Of which to Mesox: £274,744
- Competition: Innovate UK Smart grants: January 2023
- Competition year: 2023/24
- Project: ASD3MAP: Amorphous Solid Dispersion Digital Design and Manufacturing Platform for rapid and resource-efficient development of bioavailable medicines
- Sector: Pharmaceutical formulation
- UKRI project record: Gateway to Research, project 10078996
- Dataset: Innovate UK funded projects, published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title are taken from UKRI’s published record for this project.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
